Levetiracetam G.L. Pharma

Levetiracetam, the active ingredient in Levetiracetam G.L. Pharma, is an anticonvulsant presented as a tablet for oral use. It is used to manage partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients with epilepsy, and is prescribed by neurologists worldwide.

GNH USA supplies Levetiracetam G.L. Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across EU and global markets.

Levetiracetam is an anticonvulsant indicated for several seizure types and is used as adjunct therapy in these conditions.

- Partial seizures: reduces the frequency of focal onset seizures in patients with epilepsy. - Generalized tonic‑clonic seizures: helps control convulsive episodes in patients with generalized epilepsy. - Myoclonic seizures: decreases myoclonic jerks in appropriate seizure disorders.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness: feeling of sleepiness or fatigue. - Dizziness: light‑headed sensation, especially when standing quickly. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing requiring immediate medical attention. - Psychiatric symptoms: new or worsening depression, suicidal thoughts, or aggression. - Blood abnormalities: rare cases of leukopenia or thrombocytopenia.

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use. - Renal impairment: adjust dose based on creatinine clearance. - History of psychiatric disorders: monitor mood and behavior for changes. - Concomitant CNS depressants: assess for additive sedation. - Pregnancy: risk unknown, weigh benefits against potential risks. - Elderly patients: start at lower dose and titrate cautiously. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing seizure control. - Phenobarbital: can lower levetiracetam concentrations, potentially compromising effectiveness.

Moderate Interactions (Monitor Closely): - Alcohol: additive CNS depression may increase drowsiness. - Other antiepileptic drugs (e.g., valproate, lamotrigine): monitor for additive side effects. - Oral contraceptives: levetiracetam may slightly reduce hormonal efficacy; consider alternative contraception.